Palforzia Will Be a New Treatment for Peanut Allergy

Palforzia, the first FDA-approved treatment for peanut allergy, may pop up on home med lists.

Palforzia is a peanut allergen powder given orally to allergic patients 4 to 17 years old. The goal is to decrease sensitivity to small amounts of slowly increasing exposure.

Palforzia doesn't allow patients to freely eat peanut products...they'll still have to follow a peanut-free diet. But it may minimize an allergic reaction from accidental exposure.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals